Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications.
Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications. Blood Adv. 2022 09 27; 6(18):5345-5355.